Dr. Reddy's Invests $10M in Coya Therapeutics' Private Placement
ByAinvest
Saturday, Jan 31, 2026 6:52 am ET1min read
COYA--
RDY--
Dr. Reddy's Laboratories (RDY) invested $10 million in Coya Therapeutics' private placement, raising approximately $11.1 million to enhance manufacturing capabilities for COYA 302. The funds will be used to scale manufacturing of low-dose IL-2. Coya plans to utilize the net proceeds to enhance technical transfers and commercial preparation of COYA 302. Dr. Reddy's Laboratories has a strong presence in North America and a robust portfolio of injectables and branded generics. The company has demonstrated robust financial performance and strong financial health.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet